Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oculopharyngeal muscular dystrophy.

Seminars in neurology - 1 Jan 1999

Brais B, Rouleau G A, Bouchard J P, Fardeau M, Tomé F M

Abstract excerpt

Autosomal dominant oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disease with worldwide distribution. It usually presents in the fifth or sixth decades with progressive dysphagia, eyelid ptosis, and proximal limb weakness. Unique intranuclear filament inclusions in skeletal muscle fibers are its morphological hallmark. Surgical correction of the ptosis and cricopharyngeal myotomy are the only...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blepharoptosis
Share to Chromosomes, Human, Pair 14
Share to Deglutition Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscle Weakness

Share to Muscular Dystrophies

Share to Poly(A)-Binding Proteins

Share to Receptors, Cytoplasmic and Nuclear

Share to Trinucleotide Repeats

Source

Identifiers

PMID: 10711989
DOI: 10.1055/s-2008-1040826

Genes

GCG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oculopharyngeal muscular dystrophy.PMID 10711989Read ↗

Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.Semantic proximity Read ↗

Oculopharyngeal muscular dystrophy: a polyalanine myopathy.Semantic proximity Read ↗

Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy.Semantic proximity Read ↗

The phenotypic and genotypic features of Chinese patients with oculopharyngeal muscular dystrophy.Semantic proximity Read ↗

Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.Semantic proximity Read ↗

Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategiesSemantic proximity Read ↗

Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNASemantic proximity Read ↗

A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.Semantic proximity Read ↗

[From gene to disease; the PABN1 gene and oculopharyngeal muscular dystrophy].Semantic proximity Read ↗

Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophySemantic proximity Read ↗

Oculopharyngodistal myopathy.Semantic proximity Read ↗

Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.